Rippe B, Venturoli D, Simonsen O, de Arteaga J (2004). «Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model». Perit Dial Int. 24 (1): 10–27. doi:10.1177/089686080402400102. PMID15104333.
Perl, J.; Nessim, S. J.; Bargman, J. M. (2011). «The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: Benefit at bench, bedside, or both?». Kidney International. 79 (8): 814–824. doi:10.1038/ki.2010.515. PMID21248712.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Rippe B, Venturoli D, Simonsen O, de Arteaga J (2004). «Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model». Perit Dial Int. 24 (1): 10–27. doi:10.1177/089686080402400102. PMID15104333.
Kawanishi, H.; Moriishi, M. (2007). «Encapsulating peritoneal sclerosis: prevention and treatment». Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis. 27 Suppl 2: S289–S292. PMID17556321.
Perl, J.; Nessim, S. J.; Bargman, J. M. (2011). «The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: Benefit at bench, bedside, or both?». Kidney International. 79 (8): 814–824. doi:10.1038/ki.2010.515. PMID21248712.